About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
SOHO 2021 Highlights on Optimal Treatment of MCL: Future Strategies
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Martin Dreyling
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Martin Dreyling
248 views
October 3, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Related Content
AUTOPLAY
ON
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
15:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on Dissecting the Biology of MCL: What Is Clinicall…
Feat.
T. Witzig
05:24
2021 ASCO Virtual Direct™ Highlights
2021 ASCO Key Takeaways on Lymphoma: Selected Trials on CLL & HL…
Feat.
M. Kamdar
17:34
2021 ASCO Virtual Direct™ Highlights
ASCO 2021 Q&A Session on Key Clinical Data in Leukemia & Lym…
Feat.
C. McMahon,
M. Kamdar
15:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Novel Salvage Therapy in Mantle Cell Lymphoma: Discussion on Agents …
Feat.
S. Rule
25:01
Indy Hematology Review
Review of Emerging Therapies and Top Trials in Hematologic Malignanc…
Feat.
R. Birhiray
32:02
2021 ASCO Virtual Direct™ Highlights
ASCO 2021 Q&A Session on New Updates in Hematologic Malignancies
Feat.
D. Maloney,
M. Percival
22:32
2021 ASCO Virtual Direct™ Highlights
2021 ASCO Q&A on Practice-Changing Abstracts in Lymphoma and Leu…
Feat.
J. Soumerai,
T. Kadia
19:41
2021 ASCO Virtual Direct™ Highlights
2021 ASCO Lymphoma and Leukemia Q&A Session: Impact of Recent Tr…
Feat.
J. Svoboda,
R. Redner
12:35
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
2019 Frontline Therapy for Mantle Cell Lymphoma: Cytarabine as a Key…
Feat.
S. Rule
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
13:07
Moffitt Cancer Center
R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?
Feat.
J. Chavez
09:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…
Feat.
J. Westin
06:33
Christopher Flowers
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
10:04
Tara Graff
How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…
11:12
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…
Feat.
A. Herrera
